The Antisense and RNAi Therapeutics Market: Future Trends and Predictions
The Antisense and RNAi Therapeutics Market Segment is poised for significant growth, projected to reach USD 18.48 billion by 2032, up from USD 4.15 billion in 2023, reflecting a robust Compound Annual Growth Rate (CAGR) of 18.05% during the forecast period from 2024 to 2032. This remarkable growth is driven by increasing investments in genetic research, advancements in RNA-based technologies,...
0 Comentários 0 Compartilhamentos 468 Visualizações 0 Anterior